On Oct. 2, 2020, the Food and Drug Administration announced it had approved Bristol-Myers Squibb’s Opdivo (nivolumab) in combination with Yervoy (ipilimumab)…
The Food and Drug Administration has issued guidance for drugmakers on how to detect and prevent potential cancer-causing nitrosamine contamination in drugs. …
The Association of Marketing and Communication Professionals has honored Drugwatch for its consequential reporting on the vaping industry’s marketing practices.
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
